Key result
Non-diabetic obese dyslipidemic subjects had significantly altered heart rate variability and inflammatory markers correlated with an increased LF:HF ratio compared to healthy controls.
Why the study?
Is heart rate variability associated with inflammatory markers and metabolic parameters in non-diabetic obese dyslipidemic middle-aged individuals?
Case-Control (n=40)
Is heart rate variability associated with inflammatory markers and metabolic parameters in non-diabetic obese dyslipidemic middle-aged individuals?
Sympathovagal imbalance and chronic low-grade inflammation are present in non-diabetic obese dyslipidemic individuals and correlate with metabolic parameters, potentially explaining their augmented risk for future cardiac morbidities.
Association in case-control study suggests autonomic-inflammation links in obese dyslipidemia; hypothesis-generating, requires prospective validation before practice change.
Background and Aim: It has been documented that obesity is associated with diabetes, hypertension and dyslipidemia that are known cardiovascular (CV) risks. However, there are few obese individuals, who do not develop diabetes early. In the present study, we have assessed the association of inflammatory markers in non-diabetic dyslipidemic obese subjects, as metabolic biomarkers have not been adequately studied in obesity without diabetes, especially in the assessment of CV risks. Methods: Twenty non-diabetic obese dyslipidemic subjects (study group) and 20 healthy non-obese subjects (control group) were included in this study. They were assessed for their body mass index (BMI) and heart rate variability (HRV) indices. Glucose, insulin, lipid profile and inflammatory markers were estimated from the fasting serum sample. Association of HRV with various parameters was determined by Pearson's correlation analysis. Results: The basal CV parameters, HRV, lipid profile, glucose, insulin and the inflammatory markers were significantly altered and correlated with ratio of low frequency to high frequency (LF: HF ratio), a marker of sympathovagal imbalance (SVI) in the study group when compared with the control group. Conclusion: SVI in the form of increased sympathetic and decreased parasymapathetic activity occurs in non-diabetic obese dyslipidemic subjects. Association of BMI, metabolic parameters and chronic low grade inflammation with LF: HF ratio may partly explain their augmented risks to future cardiac morbidities.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2014) conducted a case-control in Obesity with dyslipidemia (n=40). Obesity with dyslipidemia vs. Healthy non-obese subjects was evaluated on Heart rate variability indices, lipid profile, glucose, insulin, and inflammatory markers. Non-diabetic obese dyslipidemic subjects had significantly altered heart rate variability and inflammatory markers correlated with an increased LF:HF ratio compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: